Sinphar Pharmaceutical Co Ltd
TWSE:1734
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sinphar Pharmaceutical Co Ltd
Research & Development
Sinphar Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sinphar Pharmaceutical Co Ltd
TWSE:1734
|
Research & Development
-NT$151.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
22%
|
CAGR 10-Years
8%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Research & Development
-NT$401m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Research & Development
-NT$497.3m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-4%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Research & Development
-NT$986.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-13%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Research & Development
-NT$257.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
Research & Development
-NT$650.5m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Sinphar Pharmaceutical Co Ltd
Glance View
Sinphar Pharmaceutical Co. Ltd. is engaged in the manufacturing, processing and trading of various western medicines, therapeutic drugs, medicated cosmetics, nutriment, health care foods, and cleaning liquid. The company is headquartered in Dongshan, Yilan. The company went IPO on 2000-10-17. The firm is also engaged in the sales of functional food products. The Company’s principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The firm mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
See Also
What is Sinphar Pharmaceutical Co Ltd's Research & Development?
Research & Development
-151.4m
TWD
Based on the financial report for Dec 31, 2024, Sinphar Pharmaceutical Co Ltd's Research & Development amounts to -151.4m TWD.
What is Sinphar Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
8%
Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for Sinphar Pharmaceutical Co Ltd have been 33% over the past three years , 22% over the past five years , and 8% over the past ten years .
